Product Details
Zofran
Ondansetron Hydrochloride4 mg/5 mL
Oral Liquid
DIN/PIN/NPN
02229639
Manufacturer
Novartis Pharma Canada Inc.
Formulary Listing Date
1997-08-28
Unit Price
NA
Amount MOH Pays
NA
Coverage Status
Not a Benefit
ODB Formulary Therapeutic Classification
Therapeutic Note
NO
ATC Code
A04AA01
Interchangeable Products
| DIN/ PIN/ NPN | Brand name | Unit Price | Amount MOH pays |
|---|---|---|---|
| 02229639 | Zofran | NA | NA |
| 02490617 | Jamp Ondansetron | 0.7952 | 0.7952 |
| 02291967 | Apo-Ondansetron | 0.7952 | 0.7952 |
| 02524090 | Mint-Ondansetron Solution | 0.7952 | 0.7952 |
LU Clinical Criteria
NOEAP Criteria
| Therapeutic Class | Reimbursement Criteria |
|---|---|
| Unclassified EAP Drugs | These drugs are not currently listed in the Exceptional Access Program Reimbursement Criteria for Frequently Requested Drugs – August 8, 2023 Edition Physicians may wish to contact the EAP directly by phone at 416-327-8109 or 1-866-811-9893 or by email at EAPFeedback.MOH@ontario.ca to see if an unlisted drug product and/or indication may be considered for EAP funding. |